| 1 |
Palumbo JM, Thomas BF, Budimirovic D, Siegel S, Tassone F, Hagerman R, Faulk C, O'Quinn S, Sebree T. Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment. J Neurodev Disord 2023;15:1. [PMID: 36624400 DOI: 10.1186/s11689-023-09475-z] [Reference Citation Analysis]
|
| 2 |
de Camargo RW, de Novais Júnior LR, da Silva LM, Meneguzzo V, Daros GC, da Silva MG, de Bitencourt RM. Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review. Pharmacol Biochem Behav 2022;221:173492. [PMID: 36379443 DOI: 10.1016/j.pbb.2022.173492] [Reference Citation Analysis]
|
| 3 |
Gheasuddin Y, Galea GL. Cannabidiol impairs neural tube closure in mouse whole embryo culture. Birth Defects Res 2022;114:1186-93. [PMID: 35416425 DOI: 10.1002/bdr2.2013] [Reference Citation Analysis]
|
| 4 |
Colwell M, Flack N, Medida RL, Drown C, Faulk C, Mauro L. Effects of 5-aza-2'-deoxycytidine on DNA Methylation within Female Mouse Reproductive Tissues.. [DOI: 10.21203/rs.3.rs-1547192/v3] [Reference Citation Analysis]
|
| 5 |
Colwell M, Flack N, Medida RL, Drown C, Faulk C, Mauro L. Effects of 5-aza-2'-deoxycytidine on DNA Methylation within Female Mouse Reproductive Tissues.. [DOI: 10.21203/rs.3.rs-1547192/v2] [Reference Citation Analysis]
|
| 6 |
Bortoletto R, Colizzi M. Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis. Healthcare 2022;10:1553. [DOI: 10.3390/healthcare10081553] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 7 |
Mohammad GS, Joca S, Starnawska A. The Cannabis-Induced Epigenetic Regulation of Genes Associated with Major Depressive Disorder. Genes (Basel) 2022;13:1435. [PMID: 36011346 DOI: 10.3390/genes13081435] [Reference Citation Analysis]
|
| 8 |
Colizzi M, Bortoletto R, Costa R, Bhattacharyya S, Balestrieri M. The Autism-Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System. Int J Environ Res Public Health 2022;19. [PMID: 35565034 DOI: 10.3390/ijerph19095616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 9 |
Reece AS, Hulse GK. Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 3 - spatiotemporal, multivariable and causal inferential pathfinding and exploratory analyses of prostate and ovarian cancers. Arch Public Health 2022;80:101. [PMID: 35354499 DOI: 10.1186/s13690-022-00813-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Melas PA, Scherma M, Fratta W, Cifani C, Fadda P. Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research. Int J Mol Sci 2021;22:1863. [PMID: 33668469 DOI: 10.3390/ijms22041863] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 11 |
Wanner NM, Colwell M, Drown C, Faulk C. Developmental cannabidiol exposure increases anxiety and modifies genome-wide brain DNA methylation in adult female mice. Clin Epigenetics 2021;13:4. [PMID: 33407853 DOI: 10.1186/s13148-020-00993-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
|
